BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 12684540)

  • 1. Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene.
    Korth C; Kaneko K; Groth D; Heye N; Telling G; Mastrianni J; Parchi P; Gambetti P; Will R; Ironside J; Heinrich C; Tremblay P; DeArmond SJ; Prusiner SB
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4784-9. PubMed ID: 12684540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A traceback phenomenon can reveal the origin of prion infection.
    Kobayashi A; Asano M; Mohri S; Kitamoto T
    Neuropathology; 2009 Oct; 29(5):619-24. PubMed ID: 19659941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse-adapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture.
    Lawson VA; Vella LJ; Stewart JD; Sharples RA; Klemm H; Machalek DM; Masters CL; Cappai R; Collins SJ; Hill AF
    Int J Biochem Cell Biol; 2008; 40(12):2793-801. PubMed ID: 18590830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.
    Prusiner SB
    Dev Biol Stand; 1991; 75():55-74. PubMed ID: 1686599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human prion strain selection in transgenic mice.
    Giles K; Glidden DV; Patel S; Korth C; Groth D; Lemus A; DeArmond SJ; Prusiner SB
    Ann Neurol; 2010 Aug; 68(2):151-61. PubMed ID: 20695008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuropathological phenotype in transgenic mice expressing different prion protein constructs.
    DeArmond SJ; Yang SL; Cayetano-Canlas J; Groth D; Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):415-23. PubMed ID: 7913760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion protein transgenes and the neuropathology in prion diseases.
    DeArmond SJ; Prusiner SB
    Brain Pathol; 1995 Jan; 5(1):77-89. PubMed ID: 7767493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biology and genetics of prion diseases.
    Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):447-63. PubMed ID: 7913765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein.
    Telling GC; Scott M; Hsiao KK; Foster D; Yang SL; Torchia M; Sidle KC; Collinge J; DeArmond SJ; Prusiner SB
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9936-40. PubMed ID: 7937921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular dendritic cell of the knock-in mouse provides a new bioassay for human prions.
    Kitamoto T; Mohri S; Ironside JW; Miyoshi I; Tanaka T; Kitamoto N; Itohara S; Kasai N; Katsuki M; Higuchi J; Muramoto T; Shin RW
    Biochem Biophys Res Commun; 2002 Jun; 294(2):280-6. PubMed ID: 12051707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant-negative inhibition of prion replication in transgenic mice.
    Perrier V; Kaneko K; Safar J; Vergara J; Tremblay P; DeArmond SJ; Cohen FE; Prusiner SB; Wallace AC
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13079-84. PubMed ID: 12271119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Creutzfeldt-Jakob disease prion propagation by the A224V mutation.
    Watts JC; Giles K; Serban A; Patel S; Oehler A; Bhardwaj S; Guan S; Greicius MD; Miller BL; DeArmond SJ; Geschwind MD; Prusiner SB
    Ann Neurol; 2015 Oct; 78(4):540-53. PubMed ID: 26094969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humanized knock-in mice expressing chimeric prion protein showed varied susceptibility to different human prions.
    Taguchi Y; Mohri S; Ironside JW; Muramoto T; Kitamoto T
    Am J Pathol; 2003 Dec; 163(6):2585-93. PubMed ID: 14633630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.
    Asante EA; Gowland I; Grimshaw A; Linehan JM; Smidak M; Houghton R; Osiguwa O; Tomlinson A; Joiner S; Brandner S; Wadsworth JDF; Collinge J
    J Gen Virol; 2009 Mar; 90(Pt 3):546-558. PubMed ID: 19218199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biology and transgenetics of prion diseases.
    Prusiner SB
    Crit Rev Biochem Mol Biol; 1991; 26(5-6):397-438. PubMed ID: 1684745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prions in skeletal muscle.
    Bosque PJ; Ryou C; Telling G; Peretz D; Legname G; DeArmond SJ; Prusiner SB
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3812-7. PubMed ID: 11904434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic models of prion disease.
    Scott MR; Supattapone S; Nguyen HO; DeArmond SJ; Prusiner SB
    Arch Virol Suppl; 2000; (16):113-24. PubMed ID: 11214913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic mammalian prions.
    Legname G; Baskakov IV; Nguyen HO; Riesner D; Cohen FE; DeArmond SJ; Prusiner SB
    Science; 2004 Jul; 305(5684):673-6. PubMed ID: 15286374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into prion strains and neurotoxicity.
    Aguzzi A; Heikenwalder M; Polymenidou M
    Nat Rev Mol Cell Biol; 2007 Jul; 8(7):552-61. PubMed ID: 17585315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.